[1]
H. Liu, “Transarterial Chemoembolization plus Apatinib with or without Camrelizumab for the Treatment of Advanced HBV-related Hepatocellular Carcinoma”, JGLD, vol. 32, no. 2, pp. 182–189, Jun. 2023.